Know Cancer

or
forgot password

    • cancer clinical trials in tualatin, OR

    • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Breast Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Brain and Central Nervous System Tumors
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Lung Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - Northwest Cancer Specialists, PC - Tualatin
    Tualatin, Oregon 97062
    Chronic Lymphocytic Leukemia
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Kidney Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
    Legacy Meridian Park Medical Center
    Tualatin, Oregon 97062
    Colorectal Cancer Metastatic
    Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
    Legacy Meridian Park Medical Center
    Tualatin, Oregon 97062
    Unresectable Hepatocellular Carcinoma
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Melanoma (Skin)
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Bladder Cancer
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Lung Cancer
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Lung Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Pancreatic Cancer
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Esophageal Cancer
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Breast Cancer
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Esophageal Cancer
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Sarcoma
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Legacy Meridian Park Hospital
    Tualatin, Oregon 97062
    Brain and Central Nervous System Tumors